Science Corp Hits Unicorn Status With $230M for Brain Implants
Neurotechnology startup Science Corp lands $230M at a $1.25B valuation to bring its blindness implant to market.
Science Corp just crossed the unicorn threshold. The brain technology startup pulled in $230 million in fresh funding at a $1.25 billion valuation, pushing its total capital raised to $489 million.
The money has a clear mission: commercialize the company's implant designed to restore sight in blind patients. But Science Corp isn't stopping there — the funding will also fuel development of more advanced brain-computer interface devices.
The raise signals serious investor appetite for neurotechnology, a field that's rapidly moving from sci-fi concept to clinical reality. With nearly half a billion dollars in the bank, Science Corp is positioning itself as a major player in the BCI space.
The blindness implant represents the company's most immediate commercial opportunity, but the broader ambition clearly extends deep into next-generation neural hardware.